Do oral contraceptives improve vocal quality? Limited trial on low-dose formulations

Obstet Gynecol. 2003 Apr;101(4):773-7. doi: 10.1016/s0029-7844(02)03126-5.

Abstract

Objective: To evaluate the effect of low-dose monophasic oral contraceptives on female vocal quality.

Methods: Acoustic voice parameters of six women who use oral contraceptives and six women who do not were evaluated repeatedly during the menstrual cycle. Frequency and amplitude variations were measured using a computerized voice analysis program. Repeated-measures analysis of variance was performed to test differences between groups for each acoustic voice parameter.

Results: Vocal stability among the women who use oral contraceptives was significantly better than among those who did not use oral contraceptives (P <.05). Specifically, amplitude and frequency variations between successive vocal cycles were smaller in women using oral contraceptives in comparison with the control group (.24 dB versus.37 dB and.86% versus 1.27% for amplitude and frequency variations, respectively).

Conclusion: Contrary to the reports of adverse effects that high-dose pills have on voice, low-dose oral contraceptives show a favorable influence on voice in young women.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Adult
  • Contraceptives, Oral, Combined / administration & dosage
  • Contraceptives, Oral, Combined / pharmacology*
  • Ethinyl Estradiol / administration & dosage
  • Ethinyl Estradiol / pharmacology*
  • Female
  • Humans
  • Menstrual Cycle
  • Norpregnenes / administration & dosage
  • Norpregnenes / pharmacology*
  • Speech Acoustics
  • Voice Quality / drug effects*

Substances

  • Contraceptives, Oral, Combined
  • Norpregnenes
  • Gestodene
  • Ethinyl Estradiol